Risk of Project Interruption or Delay Due to Infectious Diseases or Large-Scale Disasters
First written in FY2020. 12 of 14 entries say "Restated". Latest entry: FY2025.
0 other companies' latest entry also says "Restated".
- FY2025RestatedAnnual report
「To prepare for outbreaks of infectious diseases, earthquakes and other large-scale disasters, our group has maintained systems and operational procedures for such emergencies during normal times, with the cooperation of customers and others. However, if an outbreak of an infectious disease or a large-scale disaster occurs on a scale or with consequences beyond expectations, it may affect our group's business results through recovery costs, project interruptions or postponements, and other factors.」
Reconfirmed the group's preparedness during normal times for infectious diseases and large-scale disasters, as well as the risks of recovery costs and project interruptions arising from events beyond expectations. - FY2024RestatedAnnual report
「To prepare for outbreaks of infectious diseases, earthquakes and other large-scale disasters, our group has maintained systems and operational procedures for such emergencies during normal times, with the cooperation of customers and others. However, if an outbreak of an infectious disease or a large-scale disaster occurs on a scale or with consequences beyond expectations, it may affect our group's business results through recovery costs, project interruptions or postponements, and other factors.」
Reconfirmed the group's preparedness during normal times for infectious diseases and large-scale disasters, as well as the risks of recovery costs and project interruptions arising from events beyond expectations. - FY2024-Q3RestatedAnnual report
「During the nine-month period ended [the current third quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The company explains that there have been no new business or other risks, nor any material changes to the risks of infectious diseases, large-scale disasters and other risks described in the previous fiscal year. - FY2024-Q2RestatedAnnual report
「During the six-month period ended [the current second quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The company explains that there have been no new business or other risks, nor any material changes to the risks of infectious diseases, large-scale disasters and other risks described in the previous fiscal year. - FY2024-Q1RestatedAnnual report
「During the three-month period ended [the current first quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The company explains that there have been no new business or other risks, nor any material changes to the risks of infectious diseases, large-scale disasters and other risks described in the previous fiscal year. - FY2023RestatedAnnual report
「To prepare for outbreaks of infectious diseases, earthquakes and other large-scale disasters, our group has maintained systems and operational procedures for such emergencies during normal times, with the cooperation of customers and others. However, if an outbreak of an infectious disease or a large-scale disaster occurs on a scale or with consequences beyond expectations, it may affect our group's business results through recovery costs, project interruptions or postponements, and other factors.」
Reiterated the group's preparedness during normal times for infectious diseases and large-scale disasters, as well as the risks of recovery costs and project interruptions arising from events beyond expectations. - FY2023-Q3RestatedAnnual report
「During the nine-month period ended [the current third quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The company explains that there have been no new business or other risks, nor any material changes to the risks of infectious diseases, large-scale disasters and other risks described in the previous fiscal year. - FY2023-Q2RestatedAnnual report
「During the six-month period ended [the current second quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The company explains that there have been no new business or other risks, nor any material changes to the risks of infectious diseases, large-scale disasters and other risks described in the previous fiscal year. - FY2022RestatedAnnual report
「To prepare for outbreaks of infectious diseases, earthquakes and other large-scale disasters, our group has maintained systems and operational procedures for such emergencies during normal times, with the cooperation of customers and others. However, if an outbreak of an infectious disease or a large-scale disaster occurs on a scale or with consequences beyond expectations, it may affect our group's business results through recovery costs, project interruptions or postponements, and other factors.」
Reiterated the group's preparedness during normal times for infectious diseases and large-scale disasters, as well as the risks of recovery costs and project interruptions arising from events beyond expectations. - FY2022-Q3RestatedAnnual report
「During the nine-month period ended [the current third quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The company explains that there have been no new business or other risks, nor any material changes to the risks of infectious diseases, large-scale disasters and other risks described in the previous fiscal year. - FY2022-Q2RestatedAnnual report
「During the six-month period ended [the current second quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The company explains that there were no new business or other risks and no material changes to the risks described in the previous fiscal year. - FY2022-Q1RestatedAnnual report
「During the three-month period ended [the current first quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The company explains that there were no new business or other risks and no material changes to the risks described in the previous fiscal year. - FY2021WorsenedAnnual report
「Even after the beginning of FY2021, waves of the spread of COVID-19 continued intermittently in conjunction with the emergence of variants. Although vaccination progressed and preventive measures became more widespread, the outlook for the Japanese economy as a whole was expected to remain unclear for the time being.」
The company explained that the spread of COVID-19, accompanied by variants, was expected to continue intermittently in FY2021 and that economic uncertainty had persisted and intensified. It did not state that company-specific impacts such as project interruptions or delays had occurred. - FY2020First statedAnnual report
「Assuming the occurrence of an infectious disease outbreak or a large-scale disaster such as an earthquake, our group has systems and operational procedures in place during normal times to prepare for such emergencies. However, if an infectious disease outbreak or large-scale disaster occurs on a scale or with effects exceeding our assumptions, our group’s results of operations may be affected by recovery costs and project interruptions or delays.」
While implementing system and operational measures to prepare for infectious disease outbreaks and large-scale disasters, the company newly disclosed as a separate risk the possibility of recovery costs and project interruptions or delays resulting from events exceeding expectations.